View in EDS HTML Full Text PDF Full Text

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
Authors: File DM; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pascual T; Hospital Universitario, 12 de Octubre, Madrid, Spain.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Deal AM; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Wheless A; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Perou CM; Department of Genetics, Chapel Hill, NC, USA., Claire Dees E; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA., Carey LA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Lisa_Carey@med.unc.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Nov; Vol. 196 (1), pp. 153-162. Date of Electronic Publication: 2022 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36008651
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22File+DM%22">File DM</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pascual+T%22">Pascual T</searchLink>; Hospital Universitario, 12 de Octubre, Madrid, Spain.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA.<br /><searchLink fieldCode="AU" term="%22Deal+AM%22">Deal AM</searchLink>; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA.<br /><searchLink fieldCode="AU" term="%22Wheless+A%22">Wheless A</searchLink>; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA.<br /><searchLink fieldCode="AU" term="%22Perou+CM%22">Perou CM</searchLink>; Department of Genetics, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Claire+Dees+E%22">Claire Dees E</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, 450 West Drive, CB#7295, Chapel Hill, NC, 27599-7295, USA.<br /><searchLink fieldCode="AU" term="%22Carey+LA%22">Carey LA</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Lisa_Carey@med.unc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2022 Nov; Vol. 196 (1), pp. 153-162. <i>Date of Electronic Publication: </i>2022 Aug 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36008651
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-022-06700-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 153
    Titles:
      – TitleFull: Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: File DM
      – PersonEntity:
          Name:
            NameFull: Pascual T
      – PersonEntity:
          Name:
            NameFull: Deal AM
      – PersonEntity:
          Name:
            NameFull: Wheless A
      – PersonEntity:
          Name:
            NameFull: Perou CM
      – PersonEntity:
          Name:
            NameFull: Claire Dees E
      – PersonEntity:
          Name:
            NameFull: Carey LA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 196
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1